ArticleJournal for immunotherapy of cancer2024

Durability of response to immune checkpoint blockade following treatment discontinuation and efficacy of rechallenge in advanced Merkel cell carcinoma.

Tanya Ramadoss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.